日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Aumolertinib with carboplatin-pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open-label, multicenter, randomized phase 3 study

奥莫替尼联合卡铂-培美曲塞对比奥莫替尼单药治疗EGFR和伴随肿瘤抑制基因的非小细胞肺癌(ACROSS2):一项开放标签、多中心、随机3期研究

Duan, Jian-Chun; Zhong, Jia; Sun, Bo-Yang; Zhao, Wen-Hua; Wu, Lin; Fei, Kai-Lun; Chu, Qian; Guo, Qi-Sen; Song, Qi-Bin; Yu, Yan; Zhu, Da-Xing; Liu, Xin-Yan; Zhao, Jun; Zhan, Zhi-Xiang; Li, Shi; Nie, Lei; Lin, Jie; Peng, Xiao-Dong; Zhong, Dian-Sheng; Zhou, Jin; Li, Li-Hua; Chen, Yun-Fang; Hu, Chen; Mok, Tony; Wang, Zhi-Jie; Wang, Jie

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial

一项多中心、随机、双盲、安慰剂对照的3期临床试验:在初诊晚期卵巢癌患者中,使用氟哌啶醇联合或不联合阿帕替尼作为维持治疗方案的疗效评价(FZOCUS-1):一项多中心、随机、双盲、安慰剂对照试验

Wu, Lingying; Wang, Jing; Li, Qingshui; Wang, Danbo; Zhang, Cuiying; Tang, Junying; Zhang, Guonan; Hao, Min; Yao, Desheng; Gao, Qinglei; Zhang, Youzhong; An, Ruifang; Yin, Rutie; Wang, Li; Xia, Bairong; Zhou, Qi; Yang, Hongying; Zhu, Jianqing; Jiang, Kui; Chen, Zhengzheng; Wu, Qiang; Duan, Wei; Huang, Yi; Zhang, Hui; Wei, Shuqing; Li, Guiling; Meng, Yuanguang; Wang, Ke; Yang, Xinfeng; Huang, Xianghua; Pan, Lingya; Yu, Jinjin; Lou, Ge; Zhang, Yu; Zhou, Huaijun; Guo, Xiaoqing; Yang, Hong; Cheng, Xiaodong; Li, Xiumin; Wang, Wuliang; Zhao, Hongqin; Li, Yunxia; Yang, Yingjie; Lin, An; Cheng, Wenjun; Chen, Lihong; Xie, Xiaoying; Di, Wen; Hu, Yuanjing; Chen, Mo; Wen, Hongwu; Cai, Liping; Wu, Xiaohua; Lin, Zhongqiu; Wang, Quanren; Yang, Xinfeng; Li, Ning

MALDI Matrix: Origins, Innovations, and Frontiers

MALDI矩阵:起源、创新与前沿

Wu, Ran; Liu, Rui; Hu, Hao; Qin, Liang; Chen, Lulu; Bao, Zhibin; Fu, Jinxiang; Guo, Hua; Wang, Lei; Wang, Anna; Wang, Zihan; Yang, Chenyu; Cheng, Xiangrui; Chen, Difan; Liu, Haiqiang; Jing, Yanping; Guo, Shuai; Fu, Yujie; Wang, Xiaodong

Unleashing the potential of bimetallic nanobomb-mediated STING pathway to enhance bispecific T-cell engager against colorectal cancer photo-immunotherapy

利用双金属纳米炸弹介导的STING通路增强双特异性T细胞衔接器对抗结直肠癌光免疫疗法的潜力

Mu, Min; Li, Hui; Chen, Bo; Fan, Rangrang; Zhong, Kunhong; Wang, Guoqing; Feng, Chenqian; Chen, Nianyong; Guo, Gang; Tong, Aiping; Zou, Bingwen

The consensus molecular subtypes of esophageal squamous cell carcinoma

食管鳞状细胞癌的共识分子亚型

Cui, Heyang; Zhu, Zhongxu; Xu, Enwei; Qi, Lin; Cheng, Yikun; Zhang, Yinghan; Zhang, Ling; Cheng, Matthew Yibo; Yang, Bin; Sun, Ruifang; Zhuang, Xiaofei; Xi, Yanfeng; Yan, Ting; Cheng, Caixia; Ding, Ning; Liu, Huijuan; Wang, Lu; Guo, Min; Guo, Dinghe; Zhang, Haoyu; Peng, Meilan; An, Zhekun; Weng, Yongjia; Wang, Fang; Liu, Meng; Xiong, Ruixin; Yin, Weihua; Song, Bin; Zhang, Weimin; Cheng, Xiaolong; Liu, Zhihua; Zhan, Qimin; Wang, Xin; Cui, Yongping

Perioperative penpulimab-based combination therapy in patients with resectable non-small cell lung cancer (ALTER-L043): an open-label, multicenter, randomized, phase II trial

围手术期以 Penpulimab 为基础的联合疗法治疗可切除非小细胞肺癌患者(ALTER-L043):一项开放标签、多中心、随机、II 期试验

Wang, Meng; Liu, Weiran; Guo, Hongbo; Long, Hao; Yu, Bentong; Zhao, Guofang; Wu, Jun; Yue, Dongsheng; Zhao, Xiaoliang; Li, Chenguang; Zhang, Lianmin; Wang, Shengguang; Zhang, Qiang; Zhang, Zhenfa; Wang, Changli

Serpina3c protects against metabolic dysfunction-associated steatotic liver disease in offspring induced by prenatal prednisone exposure

Serpina3c 可保护后代免受产前泼尼松暴露引起的代谢功能障碍相关的脂肪肝疾病的影响

Dai, Yongguo; Lu, Zhengjie; Peng, Yu; Liu, Kexin; Lu, Xiaoqian; Sun, Xiaoxiang; Wang, Yuxi; Yan, Xuerong; Chen, Zijie; Zhang, Ziyi; Zhang, Ning; Ailikaiti, Aihemaitijiang; Chen, Yiming; Yue, Quanrui; Guo, Yu; Chen, Liaobin; Wang, Hui

Distinct metabolomic and proteomic signatures in Parkinson's disease patients with REM sleep behavior disorder

帕金森病伴快速眼动睡眠行为障碍患者的代谢组学和蛋白质组学特征独特

Shao, Yaping; Wang, Jing; Liu, Yaping; Ni, Yang; Liu, Zijiao; Li, Yanli; Jia, Qiqi; Li, Qi; Wang, Xiaolin; Li, Tianbai; Liu, Meichen; Zhang, Shuining; Guo, Yanming; Guo, Xisa; Wang, Dali; Liu, Yang; Liu, Cong; Cai, Huaibin; Ning, Yuping; Zhang, Jihui; Xu, Guowang; Le, Weidong

Deutenzalutamide, a novel androgen receptor inhibitor, after progression on docetaxel and abiraterone in metastatic castration-resistant prostate cancer: results from the randomized phase III HC-1119-04 trial

在转移性去势抵抗性前列腺癌患者接受多西他赛和阿比特龙治疗后出现疾病进展的情况下,新型雄激素受体抑制剂氘代沙鲁胺的疗效:来自随机 III 期 HC-1119-04 试验的结果

Wu, Junlong; Li, Xinghai; Gu, Chengyuan; Hua, Lixin; Liu, Ranlu; Li, Jun; Qiu, Mingxing; Guo, Jianming; Dong, Haiying; Ji, Zhigang; Xie, Liping; Zhu, Shaoxing; Zhang, Xuhui; Chen, Peng; Jiang, Shusuan; Sun, Zhongquan; Xu, Danfeng; Chen, Hui; Shi, Benkang; Wang, Yujie; Pu, Jinxian; Perabo, Frank; Chen, Yuanwei; Ye, Dingwei

mTOR-driven integrin β4-enriched extracellular vesicles from lenvatinib-resistant hepatocellular carcinoma fuel lung metastasis via fibroblast-niche formation

来自耐乐伐替尼肝细胞癌的mTOR驱动的富含整合素β4的细胞外囊泡通过成纤维细胞微环境的形成促进肺转移。

Zou, Tiantian; Wang, Xufeng; Sun, Haoting; Hu, Beiyuan; Li, Jianhua; Guo, Yu; Tian, Zilu; Xu, Hao; Zheng, Yan; Su, Yinghan; Chan, Chak Lam; Zhu, Le; Shen, Keyu; Shen, Xiaotian; Dong, Qiongzhu; Qin, Lun-Xiu